Martí Pumarola

Metronomic treatment in immunocompetent preclinical GL261 glioblastoma: effects of cyclophosphamide and temozolomide

Margarida Julià-Sapé, Carles Arús, Ana Paula Candiota, 2017, NMR in biomedicine.

Anti‐tumour immune response in GL261 glioblastoma generated by Temozolomide Immune‐Enhancing Metronomic Schedule monitored with MRSI‐based nosological images

Margarida Julià-Sapé, Carles Arús, Sandra Ortega-Martorell, 2020, NMR in biomedicine.

Metabolomics of Therapy Response in Preclinical Glioblastoma: A Multi-Slice MRSI-Based Volumetric Analysis for Noninvasive Assessment of Temozolomide Treatment

Margarida Julià-Sapé, Carles Arús, Victor Mocioiu, 2017, Metabolites.

Convex Non-Negative Matrix Factorization for Brain Tumor Delimitation from MRSI Data

Paulo J. G. Lisboa, Margarida Julià-Sapé, Carles Arús, 2012, PloS one.